Literature DB >> 22942903

Depression in the early stages of Huntington disease.

Eric A Epping1, Jane S Paulsen.   

Abstract

Huntington disease (HD) has traditionally been considered a movement disorder, but cognitive and psychiatric symptoms also prominently factor into its clinical presentation. Depression is one of the most common psychiatric disturbances in HD, with its prevalence highest in manifest disease during stage 2, but it is also present during the illness prodrome (the period before manifestation of motor symptoms). Identification and treatment of depression in individuals with the HD mutation is an essential part of clinical management in this population, especially owing to the high risk of suicide. This article summarizes what is currently known about the presentation and treatment of depression in the early stages of HD and provides advice to clinicians treating this population.

Entities:  

Year:  2011        PMID: 22942903      PMCID: PMC3430381          DOI: 10.2217/nmt.11.45

Source DB:  PubMed          Journal:  Neurodegener Dis Manag        ISSN: 1758-2024


  38 in total

1.  Critical periods of suicide risk in Huntington's disease.

Authors:  Jane S Paulsen; Karin Ferneyhough Hoth; Carissa Nehl; Laura Stierman
Journal:  Am J Psychiatry       Date:  2005-04       Impact factor: 18.112

2.  Neural bases of dysphoria in early Huntington's disease.

Authors:  Sergio Paradiso; Beth M Turner; Jane S Paulsen; Ricardo Jorge; Laura L Boles Ponto; Robert G Robinson
Journal:  Psychiatry Res       Date:  2008-01-15       Impact factor: 3.222

3.  Correlates of apathy in Huntington's disease.

Authors:  E van Duijn; N Reedeker; E J Giltay; R A C Roos; R C van der Mast
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2010       Impact factor: 2.198

4.  Behavioral changes in Huntington Disease.

Authors:  D Craufurd; J C Thompson; J S Snowden
Journal:  Neuropsychiatry Neuropsychol Behav Neurol       Date:  2001 Oct-Dec

Review 5.  Huntington's disease: from molecular pathogenesis to clinical treatment.

Authors:  Christopher A Ross; Sarah J Tabrizi
Journal:  Lancet Neurol       Date:  2011-01       Impact factor: 44.182

6.  Apathy is not depression.

Authors:  M L Levy; J L Cummings; L A Fairbanks; D Masterman; B L Miller; A H Craig; J S Paulsen; I Litvan
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1998       Impact factor: 2.198

7.  Health-related quality of life in Huntington's disease: Which factors matter most?

Authors:  Aileen K Ho; Abigail S Gilbert; Sarah L Mason; Anna O Goodman; Roger A Barker
Journal:  Mov Disord       Date:  2009-03-15       Impact factor: 10.338

Review 8.  Psychopathology in verified Huntington's disease gene carriers.

Authors:  E van Duijn; E M Kingma; R C van der Mast
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2007       Impact factor: 2.198

9.  The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R).

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Doreen Koretz; Kathleen R Merikangas; A John Rush; Ellen E Walters; Philip S Wang
Journal:  JAMA       Date:  2003-06-18       Impact factor: 56.272

10.  Basal ganglia volume and clinical correlates in 'preclinical' Huntington's disease.

Authors:  Caroline K Jurgens; Lotte van de Wiel; Ad C G M van Es; Yvette M Grimbergen; Marie-Noëlle W Witjes-Ané; Jeroen van der Grond; Huub A M Middelkoop; Raymund A C Roos
Journal:  J Neurol       Date:  2008-12-08       Impact factor: 4.849

View more
  28 in total

1.  Increased irritability, anxiety, and immune reactivity in transgenic Huntington's disease monkeys.

Authors:  Jessica Raper; Steven Bosinger; Zachary Johnson; Gregory Tharp; Sean P Moran; Anthony W S Chan
Journal:  Brain Behav Immun       Date:  2016-07-07       Impact factor: 7.217

2.  Validation of Neuro-QoL and PROMIS Mental Health Patient Reported Outcome Measures in Persons with Huntington Disease.

Authors:  Noelle E Carlozzi; Siera Goodnight; Anna L Kratz; Julie C Stout; Michael K McCormack; Jane S Paulsen; Nicholas R Boileau; David Cella; Rebecca E Ready
Journal:  J Huntingtons Dis       Date:  2019

Review 3.  'The clocks that time us'--circadian rhythms in neurodegenerative disorders.

Authors:  Aleksandar Videnovic; Alpar S Lazar; Roger A Barker; Sebastiaan Overeem
Journal:  Nat Rev Neurol       Date:  2014-11-11       Impact factor: 42.937

4.  Worsening of movement disorder following treatment with electroconvulsive therapy in a patient with Huntington's disease.

Authors:  Hesitha Abeysundera; Allan Campbell; Shanthi Sarma
Journal:  BMJ Case Rep       Date:  2019-08-10

5.  Characterization of depression in prodromal Huntington disease in the neurobiological predictors of HD (PREDICT-HD) study.

Authors:  Eric A Epping; James A Mills; Leigh J Beglinger; Jess G Fiedorowicz; David Craufurd; Megan M Smith; Mark Groves; Kelly R Bijanki; Nancy Downing; Janet K Williams; Jeffrey D Long; Jane S Paulsen
Journal:  J Psychiatr Res       Date:  2013-06-19       Impact factor: 4.791

6.  Association between spinocerebellar ataxias caused by glutamine expansion and psychiatric and neuropsychological signals - a literature review.

Authors:  Uanda Cristina Almeida-Silva; Jaime Eduardo Cecílio Hallak; Wilson Marques Júnior; Flávia de Lima Osório
Journal:  Am J Neurodegener Dis       Date:  2013-06-21

Review 7.  Risk factors of suicidal ideation in Huntington's disease: literature review and data from Enroll-HD.

Authors:  Philipp Honrath; Imis Dogan; Olga Wudarczyk; Katharina S Görlich; Mikhail Votinov; Cornelius J Werner; Beate Schumann; Rena T Overbeck; Jörg B Schulz; Bernhard G Landwehrmeyer; Raquel E Gur; Ute Habel; Kathrin Reetz
Journal:  J Neurol       Date:  2018-08-27       Impact factor: 4.849

8.  Sex Differences in Huntington's Disease: Evaluating the Enroll-HD Database.

Authors:  Samantha Hentosh; Liang Zhu; Jorge Patino; J Weldon Furr; Natalia P Rocha; Erin Furr Stimming
Journal:  Mov Disord Clin Pract       Date:  2021-03-08

9.  Depressive symptom severity is related to poorer cognitive performance in prodromal Huntington disease.

Authors:  Megan M Smith; James A Mills; Eric A Epping; Holly J Westervelt; Jane S Paulsen
Journal:  Neuropsychology       Date:  2012-07-30       Impact factor: 3.295

10.  Apathy Is Related to Cognitive Control and Striatum Volumes in Prodromal Huntington's Disease.

Authors:  Maria B Misiura; Jennifer Ciarochi; Jatin Vaidya; Jeremy Bockholt; Hans J Johnson; Vince D Calhoun; Jane S Paulsen; Jessica A Turner
Journal:  J Int Neuropsychol Soc       Date:  2019-02-26       Impact factor: 2.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.